Cambridge-based digital health platform Healthera today announced its £3m Series A, led by ADV with participation from Cambridge Enterprise to scale across the UK
Repeat medical prescriptions are used by millions in the UK each year and many more across the world. Paperwork, physical appointments and lack of focus on patients’ needs make this an all too often inefficient process for all involved.
Healthera is tackling this by bringing clinical services, prescription and medicine intake monitoring in one consumer platform which has seen rapid uptake from pharmacists and patients since launching in Q4 2017. We expect to see this user base grow even more rapidly as the team expands across the UK and beyond towards a time of effortless prescription for those in need.
The platform works by connecting patients to a network of hundreds of pharmacies and NHS GPs, allowing them to order and track their prescriptions, access clinical services, and monitor their medication intake in one digital end-to-end solution.
In 2016 there were over 1 billion prescription items in the UK alone. Most still rely on manual and inefficient methods to obtain prescriptions from their healthcare providers – GPs and pharmacies – often involving lots of paperwork and physical visits.
The opportunity for Healthera is to build the platform which digitises medicine for 98% of patients, community pharmacies and GPs. Initially the team’s focus is on assisting patients to order repeat prescriptions, but there’s potential for expansion into OTC’s, data-led primary care, and real-world pharmaceutical insight.
University of Cambridge alumni Quintus Liu, Martin Hao and Jin Dai founded Healthera in 2015 during their last year of study. They raised some pre-seed funding and Healthera was incubated by Silicon Valley entrepreneurs through Founder.org.
Quintus Liu, CEO at Healthera, said: “Over the past months, Healthera’s platform has won the confidence of the market as shown by the speed of adoption among patients, healthcare professionals, and NHS organizations. With this investment led by cornerstone investors ADV, Cambridge Enterprise, and Future Care Capital, we will be accelerating our expansion into every household, and soon, multiple healthcare verticals.”
Since commercially launching in late 2017, Healthera now connects over 500 pharmacies and GPs, tens of thousands of patients, and is partnering with NHS local authorities (CCG). Its app is listed on the NHS Digital apps library, and has an ongoing NHS-funded patient benefit research with Institute of Public Health, University of Cambridge.
If you’ve got a big vision for the future and would like long term, patient venture backing, please share your ambition with us. Three members of our investment team will review your opportunity and feed back within a few working days.